BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 8320811)

  • 1. [Severity of myasthenia gravis is related to the degree of neuromuscular blocking effect by isoflurane].
    Kadosaki M; Enzan K; Horiguchi T; Komatsu H; Suzuki M
    Masui; 1993 Jun; 42(6):906-9. PubMed ID: 8320811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isoflurane and mivacurium chloride neuromuscular blockade in patients with myasthenia gravis.
    Stillwell R; Mangar D; Turnage WS
    Nurse Anesth; 1993 Dec; 4(4):193-7. PubMed ID: 8136401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuromuscular effects of isoflurane in patients with myasthenia gravis.
    Nilsson E; Muller K
    Acta Anaesthesiol Scand; 1990 Feb; 34(2):126-31. PubMed ID: 2305613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neuromuscular junction: pharmacology, toxicology and clinical use of neuromuscular blocking agents].
    Conte-Camerino D; Siro-Brigiani G
    Clin Ter; 1975 Mar; 72(5):461-91. PubMed ID: 773593
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of atracurium in myasthenic patients undergoing thymectomy.
    Huang YG; Luo AL; Luo LK
    Proc Chin Acad Med Sci Peking Union Med Coll; 1990; 5(2):102-6. PubMed ID: 2243832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myasthenia gravis in children and its anaesthetic implications.
    Brown TC; Gebert R; Meretoja OA; Shield LK
    Anaesth Intensive Care; 1990 Nov; 18(4):466-72. PubMed ID: 2268010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute effects of verapamil on neuromuscular transmission in patients with myasthenia gravis.
    Lee SC; Ho ST
    Proc Natl Sci Counc Repub China B; 1987 Jul; 11(3):307-12. PubMed ID: 2827211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myasthenia gravis and atracurium. A case report.
    Macdonald AM; Keen RI; Pugh ND
    Br J Anaesth; 1984 Jun; 56(6):651-4. PubMed ID: 6326789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of napping on neuromuscular fatigue in myasthenia gravis.
    Kassardjian CD; Murray BJ; Kokokyi S; Jewell D; Barnett C; Bril V; Katzberg HD
    Muscle Nerve; 2013 Nov; 48(5):816-8. PubMed ID: 23836427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A serum factor blocking neuromuscular transmission in myasthenia gravis: electrophysiological study with intracellular microelectrodes (author's transl)].
    Shibuya N
    Rinsho Shinkeigaku; 1978 Apr; 18(4):177-84. PubMed ID: 212240
    [No Abstract]   [Full Text] [Related]  

  • 11. [Neuromuscular transmission in patients with myasthenia gravis treated by plasmapheresis and hemosorption].
    Marshaniia ZS; Sanadze AG; Kil'diushevskiĭ AV; Startsev AI
    Klin Med (Mosk); 1987 Jul; 65(7):107-10. PubMed ID: 2822998
    [No Abstract]   [Full Text] [Related]  

  • 12. Management of myasthenia gravis.
    Saperstein DS; Barohn RJ
    Semin Neurol; 2004 Mar; 24(1):41-8. PubMed ID: 15229791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Search for a neuromuscular blocking agent in the blood of patients with myasthenia gravis.
    NASTUK WL; STRAUSS AJ; OSSERMAN KE
    Am J Med; 1959 Mar; 26(3):394-409. PubMed ID: 13626994
    [No Abstract]   [Full Text] [Related]  

  • 14. Neuromuscular blockade.
    Neigh JL
    Surg Clin North Am; 1975 Aug; 55(4):837-50. PubMed ID: 241125
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical pharmacology of the neuromuscular junction in myasthenia gravis. (Preliminary communication)].
    Jurenić D; Jusić A
    Neurologija; 1978; 26(1-4):37-9. PubMed ID: 754038
    [No Abstract]   [Full Text] [Related]  

  • 16. Correlation between a patient-derived functional questionnaire and abnormal neuromuscular transmission in Myasthenia Gravis patients.
    Rostedt A; Padua L; Stålberg EV
    Clin Neurophysiol; 2005 Sep; 116(9):2058-64. PubMed ID: 16043394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of desflurane or propofol in combination with remifentanil in myasthenic patients undergoing a video-assisted thoracoscopic-extended thymectomy.
    Gritti P; Carrara B; Khotcholava M; Bortolotti G; Giardini D; Lanterna LA; Benigni A; Sonzogni V
    Acta Anaesthesiol Scand; 2009 Mar; 53(3):380-9. PubMed ID: 19243323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Contractile abnormalities of myasthenic muscle prior to neuromuscular transmission block].
    Takamori M; Mori M; Ishii N; Ide Y
    Rinsho Shinkeigaku; 1975 Feb; 15(2):65-74. PubMed ID: 1088863
    [No Abstract]   [Full Text] [Related]  

  • 19. Anesthesia issues in the perioperative management of myasthenia gravis.
    Dillon FX
    Semin Neurol; 2004 Mar; 24(1):83-94. PubMed ID: 15229795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuromuscular junction in health and disease.
    Hirsch NP
    Br J Anaesth; 2007 Jul; 99(1):132-8. PubMed ID: 17573397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.